Anti-Human PD-L1 (B7-H1) (29E.2A3)
PD-L1 (B7-H1) Monoclonal Antibody for FC
Host / Isotype
Mouse / IgG2b, kappa
Reactivity
human and More (2)
Applications
FC
Conjugate
Unconjugated
CloneNo.
29E.2A3
验证数据展示
经过测试的应用
Positive FC detected in | PHA treated human PBMCs |
推荐稀释比
Application | Dilution |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
发表文章中的应用
KD/KO | See 1 publications below |
WB | See 1 publications below |
IHC | See 1 publications below |
产品信息
65081-1-Ig targets PD-L1 (B7-H1) in FC applications and shows reactivity with human samples.
Tested Applications | FC Application Description |
Tested Reactivity | human |
Cited Reactivity | human, mouse, rat |
Immunogen | Full length human PD-L1 种属同源性预测 |
Host / Isotype | Mouse / IgG2b, kappa |
Class | Monoclonal |
Type | Antibody |
Full Name | CD274 molecule |
Synonyms | CD274, PD-L1, PD L1, hPD-L1, B7-H1 |
GenBank Accession Number | BC069381 |
Gene Symbol | PD-L1 |
Gene ID (NCBI) | 29126 |
RRID | AB_2918384 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Affinity purification |
UNIPROT ID | Q9NZQ7 |
Storage Buffer | PBS with 0.09% sodium azide. |
Storage Conditions | Store at 2-8°C. Stable for one year after shipment. |
背景介绍
实验方案
Product Specific Protocols | |
---|---|
FC protocol for PD-L1 (B7-H1) antibody 65081-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
Acta Biomater Simultaneous targeting of TGF-β1/PD-L1 via a hydrogel-nanoparticle system to remodel the ECM and immune microenvironment for limiting adhesion formation | ||
Transl Res Immune checkpoint activity exacerbate renal interstitial fibrosis progression by enhancing PD-L1 expression in renal tubular epithelial cells
| ||
Inflammation Protective Effects of a Dihydrodiazepine Against Endotoxin Shock Through Suppression of TLR4/NF-κB/IRF3 Signaling Pathways |